Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Humaid O Al-Shamsi

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Journal of Gastrointestinal Oncology|March 11, 2017
Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancerBrandon M Meyers, Humaid O Al-Shamsi, Sara Rask, et al.
Cancers|March 11, 2023
Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant OncologyKaren Abboud, Godsfavour Umoru, Abdullah Esmail, et al.
Journal of Blood Medicine|November 11, 2024
Paving the Road for Haematopoietic Stem Cell Transplantation in the United Arab Emirates: A Single Centre's ExperiencePanayotis Kaloyannidis, Biju George, Ahmad Alrustamani, et al.
BMC Cancer|July 12, 2020
Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism - a consensus report by the emirates oncology task forceHumaid O Al-Shamsi, Ibrahim Abu-Gheida, Shabeeha K Rana, et al.
Pulmonary Therapy|July 19, 2025
Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position PaperAbdullah Shehab, Huda Al Dhanhani, Omar Alhammadi, et al.
World Journal of Surgical Oncology|May 9, 2026
Recurrent primary hyperparathyroidism with ipsilateral multifocal papillary thyroid carcinoma of classical, warthin-like, and follicular variants harboring distinct BRAF and NRAS mutations: a rare case reportShaima Ali Maghdi, Jobran M Moshi, Alanoud Awaji Hakami, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies-A Narrative ReviewHumaid O Al-Shamsi, Nadia Abdelwahed, Siddig Ibrahim Abdelwahab, et al.
Scientific Reports|January 5, 2024
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trialsSara A Almansour, Mohammad A Y Alqudah, Ziad Abuhelwa, et al.
Scientific Reports|February 6, 2026
Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trialsAhmad Y Abuhelwa, Sara A Almansour, Humaid O Al-Shamsi, et al.
Ecancermedicalscience|April 23, 2021
National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemicZineb Benbrahim, Layth Mula-Hussain, Humaid O Al-Shamsi, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of Gastrointestinal Oncology|March 11, 2017
Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancerBrandon M Meyers, Humaid O Al-Shamsi, Sara Rask, et al.
Cancers|March 11, 2023
Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant OncologyKaren Abboud, Godsfavour Umoru, Abdullah Esmail, et al.
Journal of Blood Medicine|November 11, 2024
Paving the Road for Haematopoietic Stem Cell Transplantation in the United Arab Emirates: A Single Centre's ExperiencePanayotis Kaloyannidis, Biju George, Ahmad Alrustamani, et al.
BMC Cancer|July 12, 2020
Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism - a consensus report by the emirates oncology task forceHumaid O Al-Shamsi, Ibrahim Abu-Gheida, Shabeeha K Rana, et al.
Pulmonary Therapy|July 19, 2025
Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position PaperAbdullah Shehab, Huda Al Dhanhani, Omar Alhammadi, et al.
World Journal of Surgical Oncology|May 9, 2026
Recurrent primary hyperparathyroidism with ipsilateral multifocal papillary thyroid carcinoma of classical, warthin-like, and follicular variants harboring distinct BRAF and NRAS mutations: a rare case reportShaima Ali Maghdi, Jobran M Moshi, Alanoud Awaji Hakami, et al.
Diagnostics (Basel, Switzerland)|June 26, 2026
Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies-A Narrative ReviewHumaid O Al-Shamsi, Nadia Abdelwahed, Siddig Ibrahim Abdelwahab, et al.
Scientific Reports|January 5, 2024
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trialsSara A Almansour, Mohammad A Y Alqudah, Ziad Abuhelwa, et al.
Scientific Reports|February 6, 2026
Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trialsAhmad Y Abuhelwa, Sara A Almansour, Humaid O Al-Shamsi, et al.
Ecancermedicalscience|April 23, 2021
National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemicZineb Benbrahim, Layth Mula-Hussain, Humaid O Al-Shamsi, et al.
Pageof 9